-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme Therapeutics Q3 revenue jumps 39% on ENHANZE royalty growth, lifts 2026 outlook

Reuters·11/05/2026 21:48:29

Please log in to view news